Cinacalcet Hydrochloride Impurity VI, with the CAS number 2448346-01-6, is a chemical compound that serves as an impurity associated with the synthesis of cinacalcet, a medication used to treat secondary hyperparathyroidism in patients with chronic kidney disease and to manage hypercalcemia in patients with parathyroid carcinoma. While specific characteristics of this impurity may not be widely documented, impurities in pharmaceuticals typically exhibit properties such as lower purity, distinct chemical structures, and varying solubility compared to the main active ingredient. Impurities can arise from various stages of synthesis, storage, or degradation and may affect the overall efficacy and safety profile of the final pharmaceutical product. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify impurities like Cinacalcet Hydrochloride Impurity VI, ensuring that they remain within acceptable limits as defined by regulatory standards. Understanding the characteristics of such impurities is crucial for maintaining the quality and safety of pharmaceutical formulations.

Cinacalcet Hydrochloride iMpuritVI

2448346-01-6: Cinacalcet Hydrochloride Impurity VI, with the CAS number 2448346-01-6, is a chemical compound that serves as an impurity associated with the synthesis of cinacalcet, a medication used to treat secondary hyperparathyroidism in patients with chronic kidney disease and to manage hypercalcemia in patients with parathyroid carcinoma. While specific characteristics of this impurity may not be widely documented, impurities in pharmaceuticals typically exhibit properties such as lower purity, distinct chemical structures, and varying solubility compared to the main active ingredient. Impurities can arise from various stages of synthesis, storage, or degradation and may affect the overall efficacy and safety profile of the final pharmaceutical product. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify impurities like Cinacalcet Hydrochloride Impurity VI, ensuring that they remain within acceptable limits as defined by regulatory standards. Understanding the characteristics of such impurities is crucial for maintaining the quality and safety of pharmaceutical formulations.

(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(m-tolyl)propanamide

CAS 2448346-01-6

Cinacalcet Hydrochloride iMpuritVI

(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(m-tolyl)propanamide

Ref: 54-OR96909